Insurers, PBMs, Public Citizen, Lawmakers: Mylan's EpiPen Patient Assistance Plan Falls Short

Key consumer groups, pharmacy benefit managers, the insurance industry lobby and lawmakers from both parties blasted Mylan Pharmaceuticals for its newly unveiled patient assistance plan to reduce consumers' out-of-pocket costs for EpiPens, saying the move falls far short of what is needed to address growing criticism of the company's sharp price hike for the auto-injector product. Mylan announced Thursday (Aug. 25) it is reducing the auto-injector's cost through the use of a savings card that will cover up to $300...